Post-Marketing Surveillance of Adverse Events for the Recombinant Zoster Vaccine Among the Population over 50 Years Old in Hangzhou, China
In summary, RZV demonstrated a favorable safety profile. However, continued monitoring and research on the long-term safety implications of RZV are needed.
Authors
- Jian Du (ORCID: https://orcid.org/0000-0001-5010-7859)
- Xuechao Zhang (ORCID: https://orcid.org/0009-0006-9042-2478)
- Yuyang Xu (ORCID: https://orcid.org/0000-0002-3962-3526)
- Yan Liu (ORCID: https://orcid.org/0000-0002-3108-3721)
- Jing Wang (ORCID: https://orcid.org/0000-0001-6038-7559)
- Jiayin Han
Institutions
- Hangzhou Center for Disease Control and Prevention (CN)
Publication Details
- Journal
- Vaccines
- Published
- 2024-12-06
- DOI
- https://doi.org/10.3390/vaccines12121376
- Citations
- 5
- Primary Topic
- Herpesvirus Infections and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 1.93
Funders
- Medical Science and Technology Project of Zhejiang Province